藥物成份

共有 21647 個藥物成份

Silver sulphadiazine contains not less than 98% and not more than 102% of C10H9AgN4O2S,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 68 percent,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 70%,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 90.0% and not more than 110.0% of C25H22O10；Mr482.4, expressed as silibinin, is within the range 30% m/m to 65% m/m (anhydrous extract).

關聯藥證數量
1

Silymarin exsiccated fructus cardui mariae extract containing 30%~65% of silymarin calculated as silybin.

關聯藥證數量
1

Silymarin(Milk Thistle Dry Extract) content not less than 90.0% and not more than 110.0% of the nominal content of silymarin, expressed as silibinin (C25H22O10；Mr 482.4), stated on the label. The nominal content of silymarin is within the range 52.5% m/m to 64.1% m/m (dried extract).

關聯藥證數量
1

Silymarin-mixture of the isomers silibinin, silicristin and silidianin:(C25H22O10) 1.Assay of Silymarin, determined as silibinin, per cent:From 30 to 65 2.Sum of silidianin and silicristin, per cent the total content of silymarin:From 20 to 45 3.Sum of silibianin A and silibianin B, per cent the total content of Silymarin:From 40 to 65 4.Sum of isosilibinin A and isosilibinin B, per cent the total content of silymarin:From 10 to 20

關聯藥證數量
1

Simethicone (Simeticone) content： 90.5 per cent to 99.0 per cent of poly(dimethyl-siloxane).

關聯藥證數量
1

Simethicone contains not less than 90.5% and not more than 99.0% of polydimethyl-siloxane([-(CH3)2SiO-]n), and not less than 4.0% and not more than 7.0% of silicon dioxide.

關聯藥證數量
1

Simethicone content: 90.5% - 99.0% of polydimethylsiloxane [-(CH3)2SiO-]n and 4.0% - 7.0% of silicon dioxide.

關聯藥證數量
1

Simethicone：Assay：90.5~99%

關聯藥證數量
1

Simeticone is a mixture of silicon dioxide and poly(dimethylsiloxane). The content of silica and poly(dimethylsiloxane) is 4%-7% and 90.5%-99.0%, respectively.

關聯藥證數量
1

Simmon citrate agar 24.2 g純水 1000 mL

關聯藥證數量
1

Simvastatin Assay(dry basis): 98.0-102.0%

關聯藥證數量
1

Simvastatin Content：98.0 per cent to 102.0 per cent (anhydrous substance) of C25H38O5

關聯藥證數量
1

Simvastatin contains not less than 97.0% and not more than 102.0% of C25H38O5, calculated on the dried substance.

關聯藥證數量
1

Simvastatin contains not less than 98.0 % and not more than 101.0 % of C25H38O5, calculated on the anhydrous basis.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5 calculated on dry basis.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5, calculated on the dried basis. It may contain a suitable antioxidant.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 102.0% of C25H38O5, calculated on the dried basis.

關聯藥證數量
1

Single vial pool of equal amounts of red blood cells from two group O donors.There red blood cells have been prepared as a 2~4% suspension in a buffered preservative solution containing adenine and adenosine to retard hemolysis and/or loss of antigenicity during the dating period.

關聯藥證數量
1

Single vial pool of group O red blood cells. There red blood cells have been prepared as a 4-6% suspension in a buffered preservative solution containing adenosine and adenine to retard hemolysis during the dating period.

關聯藥證數量
1

Sitagliptin Phosphate (Monohydrate) contains not less than 99.0% and not more than 101.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate Assay by HPLC (on anhydrous and solvent free basis): Not less than 98.0% w/w and not more than 102.0% w/w.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and NMT 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4 on the anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H18F6M5O5P, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% w/w and not more than 102.0% w/w of C16H15F6N5O．H3PO4．H2O, calculated on the anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O calculated on the anhydrous and solvent-free substance.

關聯藥證數量
1

Sitagliptin Phosphate contents not less than 98.0% and not more than 102.0% of C16H18F6N5P‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Sitagliptin phosphate contents not less than 98.0% and not more than 102.0% of C16H15F6N5O．H3PO4, calculated on the anhydrous basis.

關聯藥證數量
1

Sitagliptin phosphate monohydrate

關聯藥證數量
1

Slide Constituents：\np-hydroxy benzoyl choline iodide 0.049 mg(0.14μ mol)\nDially imidazole lueco dye 0.048 mg(0.10μ mol)

關聯藥證數量
1

Slide Ingredients: bromophenol blue 0.025mg (0.037 umol)

關聯藥證數量
1

Slide Ingredients: cholesterol oxidase (from Streptomyces ray fungus) 0.6 IU diarylimidazole leuco dye 0.135 mg (0.268 μmol) Other Ingredients: lipoprotein lipase, cholesterol esterase, peroxidase, ascorbate oxidase.

關聯藥證數量
1

Slide Ingredients:\nL - γ - glutamyl - p -nitroanilide 0.078 mg (0.29 μmol)\nOther Ingredients:\nglycylglycine.

關聯藥證數量
1

Slide Ingredients:\nL-alanine 0.485 mg(5.4 μmol)\nDiarylimidazole leuco dye 0.044 mg(0.0901 μmol)\nOther Ingredient:\n2 sodium α-ketoglutarate, potassium phosphate, pyruvate oxidase, peroxidase, ascorbate oxidase.\n

關聯藥證數量
1

Slide Ingredients:\nLipoprotein lipase (origin: Microorgranism) 0.40 U\ndiarylimidazole leuco olye 0.034mg (0.038 μmol)\nOther Ingredients:\nATP\nGlycerol kinase\nMagensium sulfate\nGlycerol-3-phosphate-oxidase\nPeroxidase\nAscorbate oxidase

關聯藥證數量
1

Slide Ingredients:\nLithium lactate 0.167 mg (1.8 μmol)\nnitrotetrazolium blue 0.124 mg (0.15 μmol)\nOther Ingredients:\nNAD+, Diaphorase, Ascorbate oxidase.

關聯藥證數量
1

Slide Ingredients:\ncreatine phosphate 2Na 0.268mg (1.2 μ mol)、\nNitrotetrazorium blue 0.122mg (0.15 μ mol)、\nOther Ingredient:\nADP, Glucose, Hexokinase, Glucose-6-phosphate dehydrogenase(G6PD), NAD+, Diaphorase\n\n

關聯藥證數量
1

Slide ingredient: Uricase (from: Candia utilis) 90mU Diarylimidazole leuco dye 0.05 mg (0.11μmol)\nOther ingredient: Peroxidase, Ascorbate oxidase.

關聯藥證數量
1

Slides：\nglucose oxidase (origin：black mold Aspergillus niger) 1.3U\n1,7-Dihydroxynaphthalene 0.031mg(0.19μmol)\n4-aminoantipyrine 0.11mg\nOther ungredient：\nPeroxidase

關聯藥證數量
1

Sod.Carboxymethylcellulose

關聯藥證數量
1

Sodium 150 mmol/L、Potassium 4.0 mmol/L、Chloride 6.2 mmol/L 、BUN 80mg/dL、Urea 171 mg/dL、Glucose 200mg/dL、Calcium 5.0mg/dL、Creatinine 1.0mg/dL、Phosporous 7.5mg/dL

關聯藥證數量
1

Sodium Acetate Trihydrate (分子量136.08) contains not less than 99.5% and not more than 101.0% of C2H3NaO2‧3H2O

關聯藥證數量
1

Sodium Acetate Trihydrate <0.2% Potassium Bicarbonate <0.3% Saponin <0.03% Preservatives <0.5% Nuclear Stain <0.003%

關聯藥證數量
1

Sodium Acetate Trihydrate contains not less than 99.5% and not more than 101.0% of C2H2NaO2•3H2O, calculated on the dried substance.

關聯藥證數量
1

Sodium Alginate Assay:90.8%~106%

關聯藥證數量
1

Sodium Ascorbate contains not less than 99.0% and not more than 101.0% of C6H7NaO6, calculated on the dried basis.

關聯藥證數量
1

Sodium Azide less than 0.1%; Uric acid 0.2mg/mL

關聯藥證數量
1

Sodium Azulene Sulfonate (Azulene Water Soluble) contains not less than 98.5% and not more than 101.5% of C15H17NaO3S．1/2H2O, calculated on the drying.

關聯藥證數量
1

Sodium Benzoate 347 mmol/LCaffeine 173.9 mmol/LSlfanilic acid 27 mmol/LHCL 50 mmol/LSodium Nitrite 0.36 mmol/LSodium Acetate 609 mmol/L

關聯藥證數量
1

Sodium Bicarbonate contains not less than 99.0% and not more than 100.5% of NaHCO3, calculated on the dried basis.

關聯藥證數量
1

Sodium Bicarbonate contains not less than 99.5% and not more than 100.5% of NaHCO3, calculated on the dried basis.

關聯藥證數量
1

Sodium Carbonate contains not less than 99.5 percent and not more than 100.5 percent of Na2CO3, calculated on the dried basis.

關聯藥證數量
1

Sodium Chloride 7.1g/LTris Buffer 2.0g/LEDTA-2K 0.2g/LSurfactant 0.8g/L

關聯藥證數量
1

Sodium Chloride contains not less than 99.0% and not more than 100.5% Of NaCl, calculated with reference to the dried substance.

關聯藥證數量
1

Sodium Chloride contains not less than 99.0% and not more than 100.5% of NaCl, calculated on the dried substance.

關聯藥證數量
1

Sodium Chloride contains not less than 99.0% and not more than 100.5% of NaCl, calculated with reference to the dried substance.

關聯藥證數量
1

Sodium Chloride contains not less than 99.5% and not more than 100.5% of NaCl, calculated with reference to the dried substance.

關聯藥證數量
1

Sodium Chloride.....0.780\nMonobasic Sodium Phosphate, Monohydrate.....0.145\nDibasic Sodium Phosphate, Hepta-hydrate.....0.321\nHydrogen Peroxide, 35%.....9.42\nHydrochloric Acid, 1.0N Solution.....As needed pH adjust\nSodium Hydroxide, 1.0N Solution.....As needed pH adjust\nPurified Water.....q.s. to 100% w/w\n以下空白

關聯藥證數量
1

Sodium Chloride.....7.1mg\nSodium Borate.....0.43mg\nBoric Acid.....4.3mg\nWater for injection add to make.....1.0ml\n以下空白

關聯藥證數量
1

Sodium Chloride.....9.0mg\nDisodium Edetate.....0.25mg\nPolyaminopropyl Biguanide.....0.0005mg\nSodium Borate.....0.142mg\nWater for injection add to make.....1.0mg\n以下空白

關聯藥證數量
1

Sodium Chloride.....9.0mg\nDisodium Edetate.....0.25mg\nPolyaminopropyl Biguanide.....0.0005mg\nSodium Borate.....0.142mg\nWater for injection added to make.....1ml\n以下空白

關聯藥證數量
1

Sodium Chloride.....9.0mg\nPolyhexamethylene Biguanide Hydrochloride.....0.0005mg\nDistilled Water add to.....1ml\n以下空白

關聯藥證數量
1

Sodium Citrate

關聯藥證數量
1

Sodium Citrate 3.2%

關聯藥證數量
1

Sodium Cromoglicate contains not less than 98.0% and not more than 101.0% of C23H14Na2O11, calculated with dried substance.

關聯藥證數量
1

Sodium Diclofenac contains not less than 99.0% and not more than the equivalent of 101.0% of C14H10Cl2N NaO2,calculated with reference to the dried substance.

關聯藥證數量
1

Sodium Disulfite\n(Mixture of the substances listed below with harmless additions)

關聯藥證數量
1

Sodium Fluoride (NaF) contains 98.5~100.5% (dried substance)

關聯藥證數量
1

Sodium Hyaluronan

關聯藥證數量
1

Sodium Hyaluronate NaHA 22.5mg\nPhosphate buffer solution aa qsp 1.0ml\n以下空白

關聯藥證數量
1

Sodium Hyaluronate, stabilized……….20mg/ml\nLidocaine hydrochloride………………3mg/ml\nPhosphate buffered saline……………...q.s.\n以下空白

關聯藥證數量
1

Sodium Hyaluronate, stabilized……….20mg/ml\nLidocaine hydrochloride………………3mg/ml\nPhosphate buffered saline……………...q.s.\n以下空白\n

關聯藥證數量
1

Sodium Hyaluronate.........................................1.5mg\nPotassium Chloride.......................................... 3.0mg\nSodium Chloride...............................................5.5mg\nSodium Phosphate Dibasic Dodecahydrate.........4.0mg\nSodium Phosphate Monobasic Dihydrate............0.6mg\n以下空白\n

關聯藥證數量
1

Sodium Hyaluronate.........................10mg\nSodium Chloride...............................8.5mg\nSodium Phosphate, Dibasic...............0.4mg\nSodium Phosphate, Monobasic..........0.03mg\nWater for injection add to...................1ml\n以下空白

關聯藥證數量
1

Sodium Hyaluronate.....0.100 g.;\nSodium Chloride.....0.620 g.;\nBoric Acid.....0.500 g.;\nDisodium Edetate.....0.100 g.;\nBorax.....0.091 g.;\nPurified Water.....100 ml.\n以下空白

關聯藥證數量
1

Sodium Hyaluronate.....1.5mg;\nPotassium Chloride.....3.0mg;\nSodium Chloride.....5.5mg;\nSodium Phosphate Dibasic Dodecahydrate.....4.0mg;\nSodium Phosphate Monobasic Dihydrate.....0.6mg\n以下空白

關聯藥證數量
1

Sodium Hyaluronate.....10mg;\nNa2HPO4．12H2O.....1.344mg;\nNaH2PO4．2H2O.....0.04mg;\nNac1.....8.5mg;\nWater for Injection\n以下空白

關聯藥證數量
1

Sodium Hyaluronate.....10mg\nSodium Chloride.....8.5mg\nDisodium Hydrogen Phosphate, Sodium Dihydrogen Phosphate, 和適量的注射用水加至1ml。\n以下空白

關聯藥證數量
1

Sodium Hyaluronate.....25.5mg\nPhosphate buffer Solution.....1.0ml\n以下空白

關聯藥證數量
1

Sodium Hyaluronate………10mg\nSodium chloride……………8.5mg\nSodium monohydrogenphosphate-12H2O………0.6mg\nSodium dihydrogenphosphate-2 H2O…………0.05mg\nWater for injection add to………………1.0ml\n以下空白

關聯藥證數量
1

Sodium Hydrogen Carbonate (Sodium Bicarbonate) contains not less than 99.0% and not more than 100.5% of NaHCO3, calculated on the dried substance.

關聯藥證數量
1

Sodium Hydroxide：0.188 mol/L Picric Acid：0.05 mol/L

關聯藥證數量
1

Sodium L-asparatate , Diarylimidazole leuco dye.

關聯藥證數量
1

Sodium Lauryl Sulfate 1.7g/L

關聯藥證數量
1

Sodium Lauryl Sulfate < 3 g/L

關聯藥證數量
1

Sodium Nitrite…………….20%\nSodium Azide……………..20%\nSodium Deoxycholate…….40%\nNon-reactive Ingredients….20%\n

關聯藥證數量
1

Sodium Phosphate, Dibasic <0.3%Potassium Phosphate, Monobasic <0.05%Disodium EDTA, Dihydrate <0.03%Sodium Chloride <1.0%Potassium Chloride <0.05%Surfactant <0.002%

關聯藥證數量
1

Sodium Phosphate, Dibasic <0.3%\nPotassium Phosphate, Monobasic <0.05%\nDisodium DETA, Dihydrate <0.03%\nSodium Chloride <1.0%\nPotassium Chloride <0.05%\nSurfactant <0.002%\nPreservatives <0.04

關聯藥證數量
1

Sodium Picosulfate contains not less than 98.5% and not more than 100.5% of C18H13NNa2O8S2‧H2O, calculated on the anhydrous basis.

關聯藥證數量
1

Sodium Selenite Pentahydrate (Na2SeO3‧5H2O) contains 98.5~101.5% (Dried basis)

關聯藥證數量
1

Sodium Sulfate 12.85g/LSodium Chloride 0.6g/LTetracaine HCL 0.02g/LImidazole 3.5g/L

關聯藥證數量
1

Sodium Sulfate Anhydrous Sodium Chloride Anti-Microbial Agent Buffer Stabilizer <1.0% <0.5%<0.1%<0.1%<0.1%

關聯藥證數量
1

Sodium Sulfate Anhydrous Sodium Chloride Anti-Microbial Agent Polyoxyethylene Ether <1.50% <0.60%<0.10%<0.25%

關聯藥證數量
1

Sodium Valproate contains not less than 98.5% and not more than 101.0% of C8H15NaO2, calculated on the dried substance.

關聯藥證數量
1

Sodium acetate anhydrous contains not less than 99.0% and not more than 101.0% of C2H3NaO2, calculated on the dried basis.

關聯藥證數量
1